Cancer Therapeutics Startup Earli on China Biotech Lead

🇨🇳 Bloomberg (CN) —

AI Summary

Cyriac Roeding, CEO of cancer therapeutics startup Earli, discusses China's biotech advancements and its growing competition with the US in the industry. He reflects on the prediction made a decade ago about China's rise in biotech.

Cyriac Roeding, CEO and co-founder of cancer therapeutics startup Earli, gives his assessment of China's biotech developments, after predicting a decade ago that the country would become a main competitor to the US. He speaks with Yvonne Man on Bloomberg's The China Show." (Source: Bloomberg)

Markets Health AI & Tech cancer therapeutics biotech China startup Cyriac Roeding health innovation

Read original source →